ZA738554B - Substituted w-pentanorprostaglandins - Google Patents

Substituted w-pentanorprostaglandins

Info

Publication number
ZA738554B
ZA738554B ZA738554A ZA738554A ZA738554B ZA 738554 B ZA738554 B ZA 738554B ZA 738554 A ZA738554 A ZA 738554A ZA 738554 A ZA738554 A ZA 738554A ZA 738554 B ZA738554 B ZA 738554B
Authority
ZA
South Africa
Prior art keywords
pentanorprostaglandins
substituted
Prior art date
Application number
ZA738554A
Other languages
English (en)
Inventor
J Bindra
M Johnson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA738554B publication Critical patent/ZA738554B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA738554A 1972-11-08 1973-11-07 Substituted w-pentanorprostaglandins ZA738554B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30481372A 1972-11-08 1972-11-08

Publications (1)

Publication Number Publication Date
ZA738554B true ZA738554B (en) 1974-09-25

Family

ID=23178133

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA738554A ZA738554B (en) 1972-11-08 1973-11-07 Substituted w-pentanorprostaglandins

Country Status (29)

Country Link
JP (3) JPS5416491B2 (cs)
AR (3) AR200585A1 (cs)
AT (3) AT367034B (cs)
AU (1) AU470375B2 (cs)
BE (1) BE806995A (cs)
CA (3) CA1085831A (cs)
CH (1) CH597176A5 (cs)
CS (3) CS182791B2 (cs)
DD (4) DD118856A5 (cs)
DE (1) DE2355540C2 (cs)
DK (1) DK144247C (cs)
ES (3) ES420325A1 (cs)
FI (1) FI60389C (cs)
FR (3) FR2205335B1 (cs)
GB (3) GB1456512A (cs)
HK (3) HK28079A (cs)
HU (3) HU172703B (cs)
IE (1) IE39537B1 (cs)
IL (1) IL43589A (cs)
IN (1) IN139384B (cs)
KE (3) KE2930A (cs)
MY (3) MY7900246A (cs)
NL (1) NL164273C (cs)
NO (3) NO147836C (cs)
PH (3) PH13272A (cs)
SE (4) SE448992B (cs)
SU (4) SU584766A3 (cs)
YU (3) YU39715B (cs)
ZA (1) ZA738554B (cs)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4154950A (en) * 1975-03-31 1979-05-15 The Upjohn Company 15-Epi-15-methyl-16-phenoxy-PGE compounds
US4241215A (en) * 1975-08-22 1980-12-23 Imperial Chemical Industries Limited Prostane derivatives

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
US3986764A (en) * 1975-03-31 1976-10-19 Gte Automatic Electric Laboratories Incorporated Panel for supporting a pair of elongated mating connectors and selectively locking them together
ES449162A1 (es) * 1975-06-23 1977-12-16 Syntex Inc Un procedimiento para la preparacion de un compuesto racemi-co u 8r-antimerico.
SE7809008L (sv) * 1977-12-12 1979-06-13 Upjohn Co Anvendning av amider av prostaglandintyp for att styra eller reglera reproduktionscykeln hos individer tillhorande deggdjursarter
IN150279B (cs) * 1978-01-16 1982-09-04 Pfizer
SK3382000A3 (en) * 1997-09-09 2000-10-09 Procter & Gamble A compound having structure of aromatic substituted prostaglandins and its use for the treatment of bone disorders
CA2364948C (en) 1999-03-05 2011-04-26 Duke University C16 unsaturated fp-selective prostaglandins analogs
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
JP2002329615A (ja) * 2001-05-02 2002-11-15 Ohira Denshi Kk トロイダルコイル
US6476064B1 (en) * 2001-06-13 2002-11-05 Allergan, Inc. Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents
US20060135609A1 (en) 2004-10-21 2006-06-22 Duke University Ophthamological drugs
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1324737A (en) * 1970-11-02 1973-07-25 Upjohn Co Prostaglandins and the preparation thereof
IE37602B1 (en) * 1971-05-11 1977-08-31 Ici Ltd Cyclopentane derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4154950A (en) * 1975-03-31 1979-05-15 The Upjohn Company 15-Epi-15-methyl-16-phenoxy-PGE compounds
US4241215A (en) * 1975-08-22 1980-12-23 Imperial Chemical Industries Limited Prostane derivatives

Also Published As

Publication number Publication date
CA1088930A (en) 1980-11-04
DE2355540A1 (de) 1974-05-22
YU270780A (en) 1982-06-18
YU39715B (en) 1985-04-30
NO148998B (no) 1983-10-17
CS182794B2 (en) 1978-05-31
IL43589A0 (en) 1974-03-14
FR2279729A1 (fr) 1976-02-20
KE2931A (en) 1979-03-30
AR200585A1 (es) 1974-11-22
FR2205335B1 (cs) 1978-07-13
HU171819B (hu) 1978-03-28
HU172703B (hu) 1978-11-28
AT367034B (de) 1982-05-25
SE448992B (sv) 1987-03-30
PH13325A (en) 1980-03-13
GB1456514A (en) 1976-11-24
SE7700717L (sv) 1977-01-24
SU745362A3 (ru) 1980-06-30
KE2930A (en) 1979-03-30
PH13110A (en) 1979-11-28
SE445111B (sv) 1986-06-02
JPS5257147A (en) 1977-05-11
DK144247B (da) 1982-01-25
FR2283146A1 (fr) 1976-03-26
DE2365322B2 (de) 1977-02-24
MY7900245A (en) 1979-12-31
DD109212A5 (cs) 1974-10-20
NO149139C (no) 1984-02-29
SU893130A3 (ru) 1981-12-23
ES433046A1 (es) 1977-06-16
AR199966A1 (es) 1974-10-08
SE431756B (sv) 1984-02-27
HK27979A (en) 1979-05-11
NL7315263A (cs) 1974-05-10
YU36975B (en) 1984-08-31
NL164273C (nl) 1980-12-15
JPS5253841A (en) 1977-04-30
SE7700718L (sv) 1977-01-24
NO750535L (cs) 1974-05-09
NO147836C (no) 1983-06-22
SU584766A3 (ru) 1977-12-15
FI60389C (fi) 1982-01-11
NO148998C (no) 1984-01-25
SE7700716L (sv) 1977-01-24
DE2355540C2 (de) 1982-11-18
AR202931A1 (es) 1975-07-31
DD118856A5 (cs) 1976-03-20
IN139384B (cs) 1976-06-12
AU470375B2 (en) 1976-03-11
NO743493L (no) 1974-05-09
YU37316B (en) 1984-08-31
DK144247C (da) 1982-07-12
SU667141A3 (ru) 1979-06-05
AT353285B (de) 1979-11-12
IE39537L (en) 1974-05-08
MY7900243A (en) 1979-12-31
ES433047A1 (es) 1976-11-01
AT360672B (de) 1981-01-26
GB1456512A (en) 1976-11-24
HK28179A (en) 1979-05-11
ATA544676A (de) 1979-04-15
CS182791B2 (en) 1978-05-31
KE2932A (en) 1979-03-30
NO147836B (no) 1983-03-14
FI60389B (fi) 1981-09-30
IE39537B1 (en) 1978-11-08
PH13272A (en) 1980-02-27
JPS5416491B2 (cs) 1979-06-22
AU6224773A (en) 1975-05-08
HK28079A (en) 1979-05-11
CA1088931A (en) 1980-11-04
BE806995A (fr) 1974-05-07
CH597176A5 (cs) 1978-03-31
FR2205335A1 (cs) 1974-05-31
IL43589A (en) 1980-01-31
ATA544576A (de) 1980-06-15
DD117233A5 (cs) 1976-01-05
JPS4993342A (cs) 1974-09-05
NO149139B (no) 1983-11-14
FR2279729B1 (cs) 1978-04-28
SE436278B (sv) 1984-11-26
HU173507B (hu) 1979-05-28
ES420325A1 (es) 1976-04-16
YU288073A (en) 1982-02-28
GB1456513A (en) 1976-11-24
YU270680A (en) 1983-04-27
ATA936973A (de) 1981-10-15
MY7900246A (en) 1979-12-31
CS182793B2 (en) 1978-05-31
CA1085831A (en) 1980-09-16
DE2365322A1 (de) 1974-11-07
DD119411A5 (cs) 1976-04-20
FR2283146B1 (cs) 1981-06-19

Similar Documents

Publication Publication Date Title
CS609973A2 (en) Nosic informace
CS283873A2 (en) Zpusob rafinace tavenin zeleznych kovu
PH13272A (en) Substituted w-pentanorprostaglandins
GB1405253A (en) 1- 2-substituted-chromonyloxy-w-hydroxy-3-phenoxy-propanes
AU6329873A (en) Flameprofing
GB1407713A (en) 2-alkoxy-cephalosporins
AU5993373A (en) N-sulphenylated carbamidoximes
AU6362373A (en) N-propargylacetanilide herbicedes
GB1402226A (en) 3-cyanochromones
GB1401579A (en) Indolo-quinolizines
GB1408010A (en) Sulphamoylphenyl-imidazolidinones
ZA7392B (en) Substituted 3-cyanobenzenesulfonamides
AU5233473A (en) Nitro-imidazolyl-pyrimidines
AU6332973A (en) Bulbholders
AU5711073A (en) Benzenesulfonyl-ureas benzenesulfonyl-ureas
GB1401735A (en) Imino-lactams
HK45678A (en) Imino-isoindolinones
AU5191873A (en) Benzylpyrimidines
GB1415691A (en) Bracks
AU5983773A (en) Alkylsulphonyl-2-trifluoromethyl-benzimidazoles
GB1405254A (en) Bis- substituted-henoxy- propanes
GB1400667A (en) 4-spirocyclopropyl-androstenes
AU5900173A (en) Thiazolopyrimidines
GB1402045A (en) 11-o-methanesulphonylerythromycins
HK10479A (en) Weatherbar